Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2025
FAO-fueled OXPHOS and NRF2-mediated stress resilience in MICs drive lymph node metastasisShan-Shan Li, Baifeng Zhang, Cuicui Huang, et al.
Nature Communications|May 19, 2023
ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancerTin-Lok Wong, Jia-Jian Loh, Shixun Lu, et al.
Hepatology (Baltimore, Md.)|December 12, 2024
DGKH-mediated phosphatidic acid oncometabolism as a driver of self-renewal and therapy resistance in HCCJia Jian Loh, Kai Yu Ng, Ianto Bosheng Huang, et al.
Cell Death & Disease|February 5, 2021
The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progressionNicole Pui Yu Ho, Carmen Oi Ning Leung, Tin Lok Wong, et al.
Nature Communications|October 23, 2023
Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinomaCarmen Oi Ning Leung, Yang Yang, Rainbow Wing Hei Leung, et al.
Hepatology Communications|September 25, 2022
Loss of phospholipase Cγ1 suppresses hepatocellular carcinogenesis through blockade of STAT3-mediated cancer developmentEun-Bi Seo, Hyun-Jun Jang, Sun-Ho Kwon, et al.
JHEP Reports : Innovation in Hepatology|November 28, 2022
SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progressionMartina Mang Leng Lei, Carmen Oi Ning Leung, Eunice Yuen Ting Lau, et al.
Pageof 13